iSyncWave is a gel-free, portable EEG brain mapping device with LED photo-biomodulators. Designed especially for the early detection and supportive care of neuropsychiatric disorders such as dementia, Parkinson's disease, TBI, PTSD, ADHD, depression, etc., it is believed to help neuropsychiatric patients to treat their illnesses at both clinics and homes. It will also allow for individuals to facilitate regular check-ups to prevent degenerative neurological disorders.
AI brain mapping with EEG discovers Alzheimer's brainwave and could detect pre-clinical Alzheimer's dementia (AD). With AI analytics and brain mapping techniques, it can also serve personalized NIR-LED neuromodulation using the iSyncWave headset to enhance neuronal activity.
Brain waves slow down overall as the brain degenerates. These preclinical phenomena are difficult to detect just by inspection. But artificial intelligence (AI) technology can do this by deep learning.
iSyncWave works with iSyncMe - a mobile application that connects to iMediSync's cloud platform, iSyncBrain, the AI-driven EEG analysis platform for precision mental care.
iSyncMe also works as a telemedicine platform connecting iSyncWave's user to online doctors or mental care specialists. The advanced EEG Analysis Platform, iSyncBrain MCI classifier screens and discriminates Alzheimer or non-Alzheimer type of amnestic mild cognitive impairment (MCI) to prevent dementia at pre-clinical stage.
This endured multicenter clinical trials with results of over 90 per cent accuracy.
OVERVIEW
The Organisation is an AI-driven, EEG-centered, digital mental healthcare platform company based in Seoul, South Korea. We offer early detection, treatment, and telemedicine services for Alzheimer’s dementia as well as other neuropsychiatric disorders including Parkinson’s Disease, ADHD, depression, TBI, PTSD, and COVID Brain, through our patented online AI brain mapping solution and wearable helmet-like device with EEG measurement and therapeutics features.
Founded in 2013, as a spin-off from the National Standard Data Center for Korean EEG at Seoul National University which built Asia’s first and the world’s largest quantitative EEG normative database of healthy individuals sorted by age and sex, The organisation leverages the comprehensive database, advanced AI technology and worldwide research and development network to meet the unmet needs of individuals with neuropsychiatric disorders and professionals worldwide.
CORE CAPABILITIES
• Fast diagnostic support tool based on online QEEG brain mapping analysis with an average turn-around time of under 10 minutes.
• Reliable screening for preclinical and/or prodromal stage of Alzheimer’s disease (Sensitivity 93%, specificity 90% validated via clinical trial for amnestic mild cognitive impairment)
• State-of-the-art EEG engineering and AI application capabilities for various neuropsychiatric disorders
• Telemedicine platform converging EEG measurement wearable device with advanced analytic solution
• Rapidly expanding diagnostic pipeline for various neuropsychiatric disorders such as depression,
Parkinson’s Disease, Coma, Stoke, ADHD, and PTSD, using our proprietary AI technology and expertise.
